Cargando…
Intact indoleamine 2,3-dioxygenase activity in human chronic granulomatous disease
Chronic granulomatous disease (CGD) is characterized by a disability to produce reactive oxygen intermediates (ROI) caused by a defect of phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. A hyperinflammatory response to immune activation has been reported to contribute to the pa...
Autores principales: | Jürgens, Birgit, Fuchs, Dietmar, Reichenbach, Janine, Heitger, Andreas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946558/ https://www.ncbi.nlm.nih.gov/pubmed/20570568 http://dx.doi.org/10.1016/j.clim.2010.05.007 |
Ejemplares similares
-
Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation
por: Jürgens, Birgit, et al.
Publicado: (2010) -
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
por: Gostner, Johanna M, et al.
Publicado: (2014) -
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020) -
Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC
por: Gostner, Johanna M., et al.
Publicado: (2012) -
Assessment of neopterin and indoleamine 2,3‐dioxygenase activity in patients with seasonal influenza: A pilot study
por: Pizzini, Alex, et al.
Publicado: (2019)